Helper T cell 2 differentiation modulation

Helper T cell 2 (Th2) differentiation modulation refers to the biological and therapeutic regulation of the pathway by which naive CD4+ T cells specialize into the Th2 effector lineage. This differentiation process is primarily driven by the cytokine interleukin-4 (IL-4), which triggers the STAT6 signaling pathway to induce the expression of GATA3, the master transcription factor for Th2 cells [1][2]. Th2 cells are central to type 2 immunity, secreting signature cytokines including IL-4, IL-5, and IL-13 that promote eosinophil recruitment, mucus hypersecretion, and IgE antibody production [3]. While this response is vital for defense against parasites, overactive Th2 differentiation is the underlying cause of chronic allergic conditions such as asthma, atopic dermatitis, and allergic rhinitis [4]. Modern therapeutics modulate this process by inhibiting these cytokines or their receptors (e.g., IL-4Rα), or by targeting upstream initiators like thymic stromal lymphopoietin (TSLP), effectively dampening the type 2 inflammatory cascade [5][6]. References: [1] Zhu J, et al. Annu Rev Immunol. 2010; [2] StatPearls. Physiology, Helper T Cells. 2023; [3] Gandhi NA, et al. Nat Rev Drug Discov. 2016; [4] Gause WC, et al. Nat Rev Immunol. 2013; [5] FDA. Dupixent (dupilumab) Prescribing Information; [6] Menzies-Gow E, et al. N Engl J Med. 2021.

Other names

Th2 cell differentiationTh2 polarizationT-helper 2 cell modulationType 2 immune response modulation

Modulation of Helper T cell 2 (Th2) differentiation involves the inhibition of the signaling pathways that drive naive CD4+ T cell commitment to the Th2 phenotype. This is primarily achieved by blocking the activity of key cytokines such as IL-4 and IL-13, which signal through the IL-4 receptor alpha (IL-4Rα) to activate the transcription factor GATA3, or by targeting upstream alarmins like thymic stromal lymphopoietin (TSLP).